[PDF][PDF] Research progress of TCM combined with EGFR-TKI drugs in the treatment of advanced non-small cell lung cancer
WT Guo, WZ Shou - Adv Clin Exp Med, 2020 - pdf.hanspub.org
… In recent years, lung cancer incidence and mortality of cancer at first, but the vast majority
of patients in the first option is already late, loses the chance of radical surgery treatment, …
of patients in the first option is already late, loses the chance of radical surgery treatment, …
Gefitinib plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… Randomized phase Ⅱ study of erlotinib plus tivantinib versus erlotinib plus placebo in
previously treated non-small-cell lung cancer. J Clin Oncol 2011;29:3307-3015. …
previously treated non-small-cell lung cancer. J Clin Oncol 2011;29:3307-3015. …
[PDF][PDF] 厄洛替尼治疗老年晚期非小细胞肺癌的临床观察
杨燕霞， 毋永娟， 华云旗， 袁海清 - 2009 - scholar.archive.org
… of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer. …
-nine patients with advanced non-small cell lung cancer were treated with erlotinib 150 mg/d, …
-nine patients with advanced non-small cell lung cancer were treated with erlotinib 150 mg/d, …
[PDF][PDF] 厄洛替尼治疗70 例非小细胞肺癌的回顾性评价
吴羽华， 陶虹， 唐俊舫， 张新勇， 朱允中， 刘喆， 史鹤玲… - 2009 - core.ac.uk
… of erlotinib in non-selected non-small cell lung cancer. Methods The retrospective study
included seventy non-small-cell lung cancer patients, who were treated with erlotinib from July …
included seventy non-small-cell lung cancer patients, who were treated with erlotinib from July …